Complications and side-effects of foam sclerotherapy

Phlebology

Volumn 24, Issue 6, 2009, Pages 270-274

  Guex, J J ^a  

^a Cabinet de Médecine Vasculaire   (France)

Author keywords

Complications; Foam; Sclerotherapy

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; POLIDOCANOL; TETRADECYL SULFATE SODIUM;

ANAPHYLAXIS; ARTICLE; CHEST TIGHTNESS; COUGHING; DEEP VEIN THROMBOSIS; DRUG FATALITY; DRUG HYPERSENSITIVITY; FOAM; GAS; HEADACHE; HUMAN; INFORMED CONSENT; LEG VARICOSIS; LIQUID; LUNG EMBOLISM; MICROBUBBLE; MIGRAINE; MUSCLE NECROSIS; PATHOPHYSIOLOGY; PIGMENT DISORDER; PRIORITY JOURNAL; RISK FACTOR; SCLEROTHERAPY; SKIN NECROSIS; STROKE; THROMBOPHILIA; THROMBOPHLEBITIS; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; VARICOSIS; VISUAL DISORDER;

COUGH; DETERGENTS; DOSAGE FORMS; EMBOLISM, AIR; HUMANS; INTRACRANIAL EMBOLISM; ISCHEMIC ATTACK, TRANSIENT; MICROBUBBLES; POLYETHYLENE GLYCOLS; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SODIUM TETRADECYL SULFATE; THROMBOSIS; ULTRASONOGRAPHY, INTERVENTIONAL; VARICOSE VEINS; VISION DISORDERS;

EID: 72149127923     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2009.009049     Document Type: Article

References (31)

1. Goldman MP, Bergan JJ, Guex JJ. Complications and adverse sequelae of sclerotherapy. In: Goldman MP, Bergan JJ, Guex J-J, eds. Sclerotherapy. Treatment of Varicose and Telangiectatic Leg Veins. 4th edn. St Louis: Mosby, 2007:188-244
2. Varcoe PF. Ultrasound guided sclerotherapy: efficacy, adverse effects and dosing. An international survey. Aust N Z J Phlebol 2003;7:17-24
3. Alos P, Carrreno P, Lopez JA, Estadella B, Serra-Prat M, Mariel-lo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 2006;31:101-107 (Pubitemid 43024991)
4. Ceulen RPM, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008;358:1525-1526
5. Guex J-J, Allaert F-A, Gillet J-L, Chleir F. Immediate and midterm complications of sclerotherapy. Report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005;31:123-128
6. Guex JJ, Schliephake DE, Otto J, Mako S, Allaert FA. The French Polidocanol study on long term side effects. A survey covering 3357 patients years. Dermatol Surg 2009 (in press)
7. Guex J-J. Complications of sclerotherapy, an update. Dermatol Surg 2009 (in press)
8. Gillet JL, et al. Effets secondaires et complications de l'échosclérothérapie à la mousse des troncs saphènes: l'étude Cesmous. Phlébologie 2008;3:288-289
9. Gillet JL, Guedes JM, Guex JJ, et al. Side effects and complications of foam sclerotherapy of the great and small saphenous veins : a controlled multicentre prospective study including 1025 patients. Phlebology 2009;24:131-138
10. Bergan J, Pascarella L, Mekenas L. Venous disorders: treatment with sclerosant foam. J Cardiovasc Surg 2006;47:9-18
11. Yamaki T, Nozaki M, Sasaki K. Acute massive pulmonary embolism following high ligation combined with compression sclerotherapy for varicose veins. Dermatol Surg 1999;25:321-325 (Pubitemid 29191322)
12. Parsi K, Exner T, Low J, Ma DD, Joseph JE. In vitro effects of detergent sclerosants on antithrombotic mechanisms. Eur J Vasc Endovasc Surg 2009;38:220-228
13. Ikeda M, Kambayashi J, Iwamoto S, et al. Hemostasis activation during sclerotherapy of lower extremity varices. Thromb Res 1996;82 (1):87-95 (Pubitemid 26148563)
14. Hamel-Desnos C, Guias B, Quehé P, et al. Onséquences biologiquessur le sang circulant de la sclérothérapie à la mousse. Essai contrôlé randomisé avec ou sans compression post-porocédure. Abstract 7° congrès de la Société Française de Médecine Vasculaire. J Mal Vasc 2008;33(S2):s74-8
15. Hamel-Desnos CM, Gillet J-L, Desnos PR, Allaert FA. Sclerotherapy of varicose veins in patients with documented thrombophilia: a prospective controlled randomized study of 105 cases. Phlebology 2009;24:176-182
16. Coleridge Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006;32:577-583
17. Donnet A. Migraine et sclérothérapie à la mousse: le point de vue du neurologue. Phlébologie 2008;61:77-79
18. Neuhardt D. Emboli Detection in Middle Cerebral Artery Concurrent with Treatment of Lower Extremity Superficial Venous Insufficiency with Foam Sclerotherapy (abstract). 22nd Annual Congress of the American College of Phlebology, Marco Island, FL, November 2008
19. Raymond-Martimbeau P. Detection of patent foramen ovale before foam sclerotherapy (abstract). 21st Annual Congress of the American College of Phlebology, November 8-11 2007, Tucson, AZ
20. Morrison N. Foam sclerotherapy, how to improve results and side effects. Phlebologie 2008;37:211-220
21. Ceulen RP, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008;358:1525-1526
22. Blin E. Imagerie échocardiographique après injection de mousse sclérosante. Phlébologie 2009;62:19-22
23. Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention with STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-1404
24. Dreier JP, Kleeberg J, Petzold G, et al. Endothelin-1 potently induces Leão's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain 2002;125:102-112
25. Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory [review]. Brain 1994;117:199-210 (Pubitemid 24103394)
26. Morrison N, Neuhardt DL, Rogers CR, et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:830-836
27. Breu FX, Guggenbichler S, Wollmann J-C. 2nd European Consensus Meeting on Foam Sclerotherapy 2006 Tegernsee, Germany. VASA 2008;37(Suppl. 71):1-30
28. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43:162-164 (Pubitemid 43083525)
29. Busch RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008;23:189-192
30. BTG Varisolve®. See http://www.btgplc.com/BTGPipeline/228/ Varisolvesupregsup.html
31. Hamel-Desnos C, Guias B, Quehé P, et al. Conséquences biologiquessur le sang circulant de la sclérothérapie à la mousse. Essai contrôlé randomisé avec ou sans compression post-porocédure. Abstract 7° congrès de la Société Française de Médecine Vasculaire. J Mal Vasc 2008;33(S2):s74-8